Intellia Therapeutics Inc. Forecast and Target Price
$10.72
Intellia Therapeutics Inc. (NTLA) Share Price Forecast
Currently 34 wall-street analysts regularly analyze the financials of Intellia Therapeutics Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Intellia Therapeutics Inc. (NTLA) have a share price target of $37.3. This median of share price forecast represents a 247.91% upside from the latest price of $10.72 as on 05.07.25.
Intellia Therapeutics Inc. (NTLA) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Intellia Therapeutics Inc. (NTLA) share price will touch around $37.3 in next 12-months.
Intellia Therapeutics Inc. (NTLA) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Intellia Therapeutics Inc.'s share price and its median forecast price. As on 05.07.25, the difference is -73.51%
Intellia Therapeutics Inc. (NTLA): Difference between Current Price & Median Forecasted Price
Intellia Therapeutics Inc. (NTLA) Share Price : Analyst Recommendation
Based on 34 analysts tracking and researching Intellia Therapeutics Inc. (NTLA) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 18 | 17 | 17 |
| Outperform | 10 | 10 | 10 |
| Hold | 5 | 7 | 7 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |